MedTrace Logo

Effects of Peloid Therapy in Patients With Carpal Tunnel Syndrome

NCT07417722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-02-18

No results posted yet for this study

Summary

Carpal tunnel syndrome is a common condition caused by pressure on a nerve at the wrist. It can lead to pain, numbness, weakness, and difficulty using the hand during daily activities.

In this clinical trial, researchers will study a non-drug treatment approach for people with carpal tunnel syndrome. Participants will be randomly assigned to one of two groups. One group will receive a wrist splint and a home exercise program. The other group will receive peloidotherapy in addition to the same splint and exercise program.

Pain, hand function, daily activities, quality of life, hand strength, and ultrasound findings of the median nerve will be evaluated before treatment, at the end of treatment, and during follow-up periods.

The goal of this study is to determine whether adding peloidotherapy to wrist splint and a home exercise program provides additional benefits in reducing pain and improving hand function in people with carpal tunnel syndrome.

Conditions

  • Carpal Tunnel Syndrome (CTS)

Interventions

OTHER

Peloid Therapy

Peloid therapy is applied at 45 °C for 30 minutes per session, for a total of 15 sessions.

DEVICE

Wrist Splint

Participants used a neutral-position wrist splint as part of conservative treatment for carpal tunnel syndrome.

OTHER

Home Exercise Program

Participants performed a standardized home exercise program including median nerve gliding exercises and tendon gliding exercises for the wrist and hand.

Sponsors & Collaborators

  • Gaziosmanpasa Research and Education Hospital

    lead OTHER_GOV

Principal Investigators

  • Ebru Yılmaz Yalçınkaya, MD · Department of Physical Medicine and Rehabilitation, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey

  • Serap Seringeç Karabulut, MD · Department of Medical Ecology and Hydroclimatology, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-09-11
Completion
2026-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07417722 on ClinicalTrials.gov